Rockefeller Financial Services’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-9,533
| Closed | -$141K | – | 541 |
|
|
2017
Q3 | $141K | Sell |
9,533
-756
| -7% | -$11.2K | ﹤0.01% | 364 |
|
|
2017
Q2 | $144K | Hold |
10,289
| – | – | ﹤0.01% | 319 |
|
|
2017
Q1 | $176K | Buy |
10,289
+1,689
| +20% | +$28.9K | ﹤0.01% | 319 |
|
|
2016
Q4 | $88K | Hold |
8,600
| – | – | ﹤0.01% | 384 |
|
|
2016
Q3 | $87K | Hold |
8,600
| – | – | ﹤0.01% | 362 |
|
|
2016
Q2 | $97K | Hold |
8,600
| – | – | ﹤0.01% | 359 |
|
|
2016
Q1 | $117K | Hold |
8,600
| – | – | ﹤0.01% | 362 |
|
|
2015
Q4 | $163K | Hold |
8,600
| – | – | ﹤0.01% | 352 |
|
|
2015
Q3 | $161K | Hold |
8,600
| – | – | ﹤0.01% | 350 |
|
|
2015
Q2 | $128K | Buy |
8,600
+3,939
| +85% | +$58.6K | ﹤0.01% | 345 |
|
|
2015
Q1 | $71K | Buy |
+4,661
| New | +$71K | ﹤0.01% | 398 |
|